- Conditions
- Parkinson Disease
- Interventions
- Not listed
- Lead sponsor
- BlueRock Therapeutics
- Industry
- Eligibility
- 50 Years to 78 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2027
- U.S. locations
- 2
- States / cities
- Orange, California • New York, New York
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–7
of 7
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Parkinson Disease
- Interventions
- Human Dopaminergic Progenitor Cells
- Biological
- Lead sponsor
- iRegene Therapeutics Co., Ltd.
- Industry
- Eligibility
- 30 Years to 75 Years
- Enrollment
- 5 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2032
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Parkinson Disease
- Interventions
- Autologous midbrain dopamine neurons
- Biological
- Lead sponsor
- Penelope J. Hallett, Ph.D.
- Other
- Eligibility
- 55 Years to 80 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2028
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Induced Pluripotent Stem Cells
- Interventions
- Not listed
- Lead sponsor
- National Institute on Drug Abuse (NIDA)
- NIH
- Eligibility
- 21 Years to 65 Years
- Enrollment
- 49 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2012 – 2014
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- PD - Parkinson's Disease
- Interventions
- Human induced pluripotent stem cell-derived dopaminergic progenitors (CT1-DAP001)
- Combination Product
- Lead sponsor
- University of California, San Diego
- Other
- Eligibility
- 40 Years to 75 Years
- Enrollment
- 7 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2028
- U.S. locations
- 1
- States / cities
- La Jolla, California
- Conditions
- Parkinsons Disease (PD)
- Interventions
- bemdaneprocel, Sham surgery
- Biological · Procedure
- Lead sponsor
- BlueRock Therapeutics
- Industry
- Eligibility
- 45 Years to 75 Years
- Enrollment
- 102 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2032
- U.S. locations
- 34
- States / cities
- Scottsdale, Arizona • Sun City, Arizona • Little Rock, Arkansas + 27 more
- Conditions
- Advanced Parkinson's Disease
- Interventions
- MSK-DA01, MSK-DA01 Cell Delivery Device
- Biological · Device
- Lead sponsor
- BlueRock Therapeutics
- Industry
- Eligibility
- 50 Years to 78 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2024
- U.S. locations
- 2
- States / cities
- Orange, California • New York, New York